Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
A Bad Fit: Dan Leonard’s Leadership Style Did Not Translate At AAM
Jan 17 2023
•
By
Derrick Gingery
Dan Leonard resigned as AAM CEO on 5 December 2022 • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
More from Leadership
More from Generics Bulletin